Korro Bio Revenue and Competitors

Boston, MA USA

Location

$207.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Korro Bio's estimated annual revenue is currently $19.1M per year.(i)
  • Korro Bio's estimated revenue per employee is $155,000
  • Korro Bio's total funding is $207.5M.

Employee Data

  • Korro Bio has 123 Employees.(i)
  • Korro Bio grew their employee count by -5% last year.

Korro Bio's People

NameTitleEmail/Phone
1
Co-Founder & Executive ChairmanReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
VPReveal Email/Phone
4
CEOReveal Email/Phone
5
VP, Head CNS BiologyReveal Email/Phone
6
SVP, HR People & CultureReveal Email/Phone
7
VP, Head Data ScienceReveal Email/Phone
8
SVP & General CounselReveal Email/Phone
9
VP, Head CMCReveal Email/Phone
10
SVP, Head Platform - RNA EditingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Korro Bio?

Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body's natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients. Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause.

keywords:N/A

$207.5M

Total Funding

123

Number of Employees

$19.1M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Korro Bio News

2022-04-17 - Serial entrepreneur Nessan Bermingham on what's next for ...

The last couple of startups that you've helped found, Korro Bio and Triplet Therapeutics, both focus on RNA. I wonder if you can speak a...

2020-09-14 - China’s Wu Capital leads $91.5m Series A round in genetic firm Korro Bio

Premium Cambridge-based biotech startup Korro Bio has raised $91.5 million in a Series A funding round led by Chinese investment firm Wu Capital to boost its gene-editing therapies. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in Con ...

2020-09-14 - China’s Wu Capital leads $91.5m Series A round in genetic firm Korro Bio

Premium Cambridge-based biotech startup Korro Bio has raised $91.5 million in a Series A funding round led by Chinese investment firm Wu Capital to boost its gene-editing therapies. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in Con ...

2020-09-14 - RNA Therapeutics Company Korro Bio Raises $91.5 Million

RNA therapeutics company Korro Bio announced recently that it has raised $91.5 million in a Series A funding round to advance its novel platform for precise and single-base RNA editing to modulate protein function for therapeutic applications RNA therapeutics company Korro Bio announced recentl ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.8M123-8%N/A
#2
$24.7M1237%N/A
#3
$19.2M12416%$325M
#4
$17.2M1245%$120M
#5
$7.5M1265%N/A